insights_auto
Why is SGMOQ down 2.66%?
Dive Deeperchevron_right
SGMOQ:OTCMKTS
Sangamo Therapeutics Inc
$0.11
arrow_downward
-2.66%(-0.0029) 1D
Nov 17, 9:30:00 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SGMOQ...
Open
$0.11
High
$0.11
Low
$0.11
Mkt. cap
43.48M
Avg. vol.
1.33M
Volume
1.78K
52-wk high
$0.20
52-wk low
$0.01
EPS
-$0.38
Beta
1.69
Shares outstanding
414.29M
No. of employees
142
Open
$0.11
High
$0.11
Low
$0.11
Mkt. cap
43.48M
Avg. vol.
1.33M
Volume
1.78K
52-wk high
$0.20
52-wk low
$0.01
EPS
-$0.38
Beta
1.69
Shares outstanding
414.29M
No. of employees
142
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
·
27 minutes ago
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
FOREX.com
·
1 hour ago
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Traders Union
·
43 minutes ago
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California, that develops cell and gene therapies for severe genetic diseases. Wikipedia
About Sangamo Therapeutics Inc
CEOSandy Macrae
Employees142
Founded1995
HeadquartersRichmond, California, United States
SectorHealth Care
IndustryBiotechnology
Websitesangamo.com